Cargando…

Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives

Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubiliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Moribe, Kunikazu, Limwikrant, Waree, Higashi, Kenjirou, Yamamoto, Keiji
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095256/
https://www.ncbi.nlm.nih.gov/pubmed/21603195
http://dx.doi.org/10.1155/2011/138929
_version_ 1782203617095188480
author Moribe, Kunikazu
Limwikrant, Waree
Higashi, Kenjirou
Yamamoto, Keiji
author_facet Moribe, Kunikazu
Limwikrant, Waree
Higashi, Kenjirou
Yamamoto, Keiji
author_sort Moribe, Kunikazu
collection PubMed
description Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubilization, drug nanoparticle formation was observed using ascorbyl glycoside. Hydrophobic ascorbic acid derivatives such as ascorbyl mono- and di-n-alkyl fatty acid derivatives are used either as drugs or carrier components. Ascorbyl n-alkyl fatty acid derivatives have been formulated as antioxidants or anticancer drugs for nanoparticle formulations such as micelles, microemulsions, and liposomes. ASC-P vesicles called aspasomes are submicron-sized particles that can encapsulate hydrophilic drugs. Several transdermal and injectable formulations of ascorbyl n-alkyl fatty acid derivatives were used, including ascorbyl palmitate.
format Text
id pubmed-3095256
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30952562011-05-20 Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives Moribe, Kunikazu Limwikrant, Waree Higashi, Kenjirou Yamamoto, Keiji J Drug Deliv Review Article Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubilization, drug nanoparticle formation was observed using ascorbyl glycoside. Hydrophobic ascorbic acid derivatives such as ascorbyl mono- and di-n-alkyl fatty acid derivatives are used either as drugs or carrier components. Ascorbyl n-alkyl fatty acid derivatives have been formulated as antioxidants or anticancer drugs for nanoparticle formulations such as micelles, microemulsions, and liposomes. ASC-P vesicles called aspasomes are submicron-sized particles that can encapsulate hydrophilic drugs. Several transdermal and injectable formulations of ascorbyl n-alkyl fatty acid derivatives were used, including ascorbyl palmitate. Hindawi Publishing Corporation 2011 2011-04-26 /pmc/articles/PMC3095256/ /pubmed/21603195 http://dx.doi.org/10.1155/2011/138929 Text en Copyright © 2011 Kunikazu Moribe et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Moribe, Kunikazu
Limwikrant, Waree
Higashi, Kenjirou
Yamamoto, Keiji
Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives
title Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives
title_full Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives
title_fullStr Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives
title_full_unstemmed Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives
title_short Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives
title_sort drug nanoparticle formulation using ascorbic acid derivatives
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095256/
https://www.ncbi.nlm.nih.gov/pubmed/21603195
http://dx.doi.org/10.1155/2011/138929
work_keys_str_mv AT moribekunikazu drugnanoparticleformulationusingascorbicacidderivatives
AT limwikrantwaree drugnanoparticleformulationusingascorbicacidderivatives
AT higashikenjirou drugnanoparticleformulationusingascorbicacidderivatives
AT yamamotokeiji drugnanoparticleformulationusingascorbicacidderivatives